Foundation for the National Institutes of Health, Inc.

15 articles about Foundation for the National Institutes of Health, Inc.

• Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the Foundation for the National Institutes of Health (FNIH) Accelerating Medicines Partnership® (AMP®) Bespoke Gene Therapy Consortium (BGTC)

  2/28/2024

  Andelyn Biosciences, Inc. has been selected to manufacture adeno-associated vectors therapies in its suspension platform for several programs under the Foundation for the National Institutes of Health Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium.

• The Foundation for the National Institutes of Health Announces Appointment of Nina Kjellson and Charles Reinhart III to the Board of Directors

  1/18/2024

  The Foundation for the National Institutes of Health announces two new additions to the FNIH Board of Directors, Nina Kjellson, General Partner at Canaan, and Charles Reinhart III, Chief Financial Officer at Pacira BioSciences, Inc.

• The FNIH Awards 2023 Trailblazer Prize for Clinician-Scientists to Vinod Balachandran, M.D., from Memorial Sloan Kettering Cancer Center for Pancreatic Cancer Research

  8/24/2023

  The Foundation for the National Institutes of Health has awarded its sixth annual Trailblazer Prize for Clinician-Scientists to Vinod Balachandran, M.D., at Memorial Sloan Kettering Cancer Center, for his groundbreaking research on immunotherapies for pancreatic cancer.

• The FNIH Awards 2023 Lurie Prize in Biomedical Sciences to Navdeep S. Chandel, Ph.D. and Vamsi Mootha, M.D.

  8/10/2023

  The Foundation for the National Institutes of Health has named Navdeep S. Chandel, Ph.D., of Northwestern University Feinberg School of Medicine, and Vamsi Mootha, M.D., of Howard Hughes Medical Institute and Harvard Medical School, as recipients of the 2023 Lurie Prize in Biomedical Sciences.

• The Foundation for the National Institutes of Health Announces the Appointment of Jay Bradner, M.D. and Jim Weiss to the Board of Directors

  5/22/2023

  The Foundation for the National Institutes of Health is proud to announce two new additions to the FNIH Board of Directors, Dr. Jay Bradner and Jim Weiss.

• The Foundation for the National Institutes of Health Announces Selection of Eight Rare Diseases for the Bespoke Gene Therapy Consortium Clinical Trial Portfolio

  5/16/2023

  The Foundation for the National Institutes of Health announces the Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium has selected eight rare diseases for its clinical trial portfolio.

• Dr. Julie Gerberding Named Chief Executive Officer of the Foundation for the National Institutes of Health

  3/1/2022

  The Foundation for the National Institutes of Health announced the appointment of Dr. Julie Louise Gerberding, the 15th Director of the Centers for Disease Control and Prevention and an executive at Merck & Co., Inc., as its next Chief Executive Officer.

• Dr. Maria Freire, President and Executive Director of the FNIH, Announces Plan to Step Down after Nine Years of Service

  7/14/2021

  The Foundation for the National Institutes of Health announced the decision of Dr. Maria C. Freire to step down as FNIH President and Executive Director in September 2021.

• 2021 FNIH Lurie Prize in Biomedical Sciences Winner Revolutionized Imaging to Reveal Structures Hidden in Cells

  4/15/2021

  The Foundation for the National Institutes of Health has named Xiaowei Zhuang, Ph.D., winner of the 2021 Lurie Prize in Biomedical Sciences for pioneering the development of super-resolution microscopy and genome-scale imaging showing new spatial and functional organizations of molecules and cells.

• Lovelace Biomedical Presents on Lessons Learned from SARS-CoV-2 Animal Models

  12/15/2020

  The Foundation for the National Institutes of Health (NIH) has recently published on their website ( Home | FNIH ) a summary workshop on experience with animal models of COVID-19 (SARS-CoV-2).  Th

• 2020 FNIH Lurie Prize in Biomedical Sciences Winner Pioneered Innovative Techniques to Shed New Light on Human Health

  6/18/2020

  The Foundation for the National Institutes of Health has named Aviv Regev, Ph.D., winner of the 2020 Lurie Prize in Biomedical Sciences for laying the groundwork for the field of single-cell genomics and spearheading leading-edge technologies that enable a sharper perspective on human cells and applying them to revolutionize understanding of biology and disease.

• Foundation for the NIH Names Finalists of the 2019 Trailblazer Prize for Clinician-Scientists

  9/4/2019

  The winner will be announced and awarded the Trailblazer Prize and a $10,000 honorarium at the FNIH Annual Fall Board Dinner on Wednesday, October 23, 2019.

• Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery

  6/4/2019

  Contributing to both the Cancer and Inflammation and Immunity Steering Committees

• 2019 FNIH Lurie Prize in Biomedical Sciences Winner Uncovered the Microbiome's Critical Role in Immune Regulation

  4/3/2019

  The human body houses trillions of microscopic organisms called microbes that collectively make up a microbiome.

• Foundation for the NIH Selects 3 Finalists for the Inaugural Trailblazer Prize for Clinician-Scientists

  7/31/2018

  The Foundation for the National Institutes of Health (FNIH) has selected three finalists of the inaugural Trailblazer Prize for Clinician-Scientists (Trailblazer Prize)